CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope (vol 118, pg 3390, 2008)
Journal article published in 2009 by
Ania Skowera,
Richard J. Ellis 
,
Ruben Varela-Calvino,
Sefina Arif,
Guo Cai Huang,
Cassie Van-Krinks,
Anna Zaremba,
Chloe Rackham,
Jennifer S. Allen,
Timothy Im Tree
,
Ruben Varela-Calvino,
Sefina Arif,
Guo Cai Huang,
Cassie Van-Krinks,
Anna Zaremba,
Chloe Rackham,
Jennifer S. Allen,
Timothy Im Tree
